Yang T - Search Results

1

Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis.

Hu Y, Zhang M, Yang T, Mo Z, Wei G, Jing R, Zhao H, Chen R, Zu C, Gu T, Xiao P, Hong R, Feng J, Fu S, Kong D, Xu H, Cui J, Huang S, Liang B, Yuan X, Cui Q, Guo H, Yu Y, Feng Y, Jin C, Ren J, Chang AH, Wang D, Huang H. Hu Y, et al. Among authors: yang t. N Engl J Med. 2024 Apr 25;390(16):1467-1480. doi: 10.1056/NEJMoa2313812. N Engl J Med. 2024. PMID: 38657244

2

Different screening frequencies of carbapenem-resistant Enterobacteriaceae in patients undergoing hematopoietic stem cell transplantation: which one is better?

Yang TT, Luo XP, Yang Q, Chen HC, Luo Y, Zhao YM, Ye YS, Lai XY, Yu J, Tan YM, Wei GQ, Huang H, Shi JM. Yang TT, et al. Antimicrob Resist Infect Control. 2020 Mar 17;9(1):49. doi: 10.1186/s13756-020-0706-0. Antimicrob Resist Infect Control. 2020. PMID: 32183898 Free PMC article.

3

Zanubrutinib Treatment of Central Nervous System Posttransplant Lymphoproliferative Disorder After Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.

Yang TT, Chen WH, Zhao YM, Fu HR, Huang H, Shi JM. Yang TT, et al. Front Oncol. 2021 Apr 29;11:672052. doi: 10.3389/fonc.2021.672052. eCollection 2021. Front Oncol. 2021. PMID: 33996600 Free PMC article.

4

Successful treatment of early onset Epstein-Barr virus-negative T-cell lymphoproliferative disorder after allogeneic hematopoietic stem cell transplantation with histone deacetylase inhibitor chidamide.

Fu HR, Yang TT, Zhao YM, Tan YM, Gao QQ, Huang H, Shi JM. Fu HR, et al. Chin Med J (Engl). 2021 Apr 14;134(22):2756-2758. doi: 10.1097/CM9.0000000000001488. Chin Med J (Engl). 2021. PMID: 34845998 Free PMC article. No abstract available.

5

Comparable outcomes in patients with B-cell acute lymphoblastic leukemia receiving haploidentical hematopoietic stem cell transplantation: Pretransplant minimal residual disease-negative complete remission following chimeric antigen receptor T-cell therapy versus chemotherapy.

Yang TT, Meng Y, Kong DL, Wei GQ, Zhang MM, Wu WJ, Shi JM, Luo Y, Zhao YM, Yu J, Jing RR, Zhao MY, Zhao HL, Huang H, Hu YX. Yang TT, et al. Front Immunol. 2022 Aug 30;13:934442. doi: 10.3389/fimmu.2022.934442. eCollection 2022. Front Immunol. 2022. PMID: 36110859 Free PMC article.

6

Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy.

Kong D, Yang T, Geng J, Jing R, Zhang Q, Wei G, Huang H, Hu Y. Kong D, et al. Among authors: yang t. J Zhejiang Univ Sci B. 2022 Oct 15;23(10):876-880. doi: 10.1631/jzus.B2200128. J Zhejiang Univ Sci B. 2022. PMID: 36226540 Free PMC article.

7

Outcome after allogeneic hematopoietic stem cell transplantation following Venetoclax-based therapy among AML and MDS patients.

Yang TT, Song XL, Zhao YM, Ye BD, Luo Y, Xiao HW, Chen Y, Fu HR, Yu J, Liu LZ, Lai XY, Ye YS, Lan JP, Huang H, Shi JM. Yang TT, et al. Ann Hematol. 2022 Dec;101(12):2731-2741. doi: 10.1007/s00277-022-04983-9. Epub 2022 Nov 1. Ann Hematol. 2022. PMID: 36318288

8

Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL.

Song F, Hu Y, Zhang Y, Zhang M, Yang T, Wu W, Huang S, Xu H, Chang AH, Huang H, Wei G. Song F, et al. Among authors: yang t. J Immunother Cancer. 2023 Feb;11(2):e005701. doi: 10.1136/jitc-2022-005701. J Immunother Cancer. 2023. PMID: 36808074 Free PMC article.

9

Comparison of the prognostic predictive value of Molecular International Prognostic Scoring System and Revised International Prognostic Scoring System in patients undergoing allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms.

Yang T, Jiang B, Luo Y, Zhao Y, Ouyang G, Yu J, Lan J, Lu Y, Lai X, Ye B, Chen Y, Liu L, Xu Y, Shi P, Xiao H, Hu H, Guo Q, Fu H, Ye Y, Wang X, Sun J, Zheng W, He J, Zhao Y, Wu W, Cai Z, Wei G, Huang H, Shi J. Yang T, et al. Am J Hematol. 2023 Dec;98(12):E391-E394. doi: 10.1002/ajh.27099. Epub 2023 Sep 20. Am J Hematol. 2023. PMID: 37728241 No abstract available.

10

Relapsed/Refractory Peripheral T-Cell Lymphoma-Associated Hemophagocytic Lymphohistiocytosis With UNC13D and CD27 Germline Mutations.

Yang T, Chen R, Zhang M, Jing R, Geng J, Wei G, Luo Y, Xiao P, Hong R, Feng J, Fu S, Zhao H, Cui J, Huang S, Huang H, Hu Y. Yang T, et al. Cell Transplant. 2024 Jan-Dec;33:9636897231221887. doi: 10.1177/09636897231221887. Cell Transplant. 2024. PMID: 38183241 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18,426 results

Search Page